4,4,5,5-Tetramethyl-2-(5-methylthiophen-2-yl)-1,3,2-dioxaborolane, 95.0%, 25g

5-Fluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one, 95.0%, 25g

4-methyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione, 95.0%, 1g

3-ethoxy-4-[(3-methylbenzyl)oxy]benzaldehyde, 95.0%, 5g

Chloromethyl 4-Chlorophenyl Sulfide>98.0%(GC)5g

tert-Butyl 6-bromo-4-oxospiro[chroman-2,4'-piperidine]-1'-carboxylate, 95.0%, 1g

N-[(1R,2R)-1-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-1-HYDROXY-3-PYRROLIDIN-1-YLPROPAN-2-YL]OCTANAMIDE, 95%, 10mg

3-[(2-fluorophenyl)thio]propanoic acid, 1g

N-Boc-4-Piperidin-4-yl-butyric acid, 97.0%, 100g

[4-(2-propyn-1-yloxy)phenyl]amine hydrochloride, 95.0%, 5g

4-Iodo-2-methoxyphenol, 95.0%, 25g

Single-channel microliter pipette Eppendorf Research® plus, 250 to 2500 µl, red, 1 piece

3-Bromo-2-iodophenol, 95.0%, 1g